Randomized, open, parallel controlled clinical study of Haiai Decoction combined with oral administration of finasteride for male androgenic alopecia

Phase 1

• Conditions: androgenic alopecia

• Registration Number: ITMCTR2000003332
• Lead Sponsor: Shanghai Tongji Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

1. The typical clinical manifestations were in accordance with the diagnosis of AGA, and the degree of hair loss was in accordance with the BASP classification of androgenic hair loss;
2. In general, patients with good condition (no previous heart, systemic or scalp diseases) have not used any drugs that may affect hair growth (antihypertensive drugs, hormones, cytotoxic drugs, anti androgen drugs, etc.) within the first 3 months of the study;
3. Patients who agree to participate in observation and follow-up, are willing to receive follow-up, and can cooperate closely in the whole process.

Exclusion Criteria

1. Finasteride was taken orally 18 months before the start of the experiment;
2. Use local or systemic drugs that affect hair growth within 12 months;
3. History of hair transplantation;
4. Systemic or scalp diseases that may affect hair growth.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
P.Suchonwanit 7-point rating scale;

Secondary Outcome Measures

Name	Time	Method
Dermatology Life Quality Index;Evaluation of hair regeneration rate;Severity of Alopecia Tool, SALT;Measuring the thickness and density of hair with a dermatoscope;Using 4-point scale to evaluate patients' subjective satisfaction;